Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Cerchietti Research Lab
Explore this Website
Home
Research
Toggle Research menu options
Projects
Lab Team
Publications
News
Weill Cornell Medicine
Care
Discover
Teach
Home
Research
Lab Team
Publications
News
Home
Publications
Publications
Found 5 results
Author
Title
Type
Year
Filters:
Author
is
Chadburn, Amy
[Clear All Filters]
2018
Rutherford SC
,
Stewart EN
,
Chen Z
,
Chadburn A
,
Wehrli NE
,
van Besien K
,
Martin P
,
Furman RR
,
Leonard JP
,
Cerchietti L
. 2018.
The eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data
.
.
Leuk Lymphoma. 59(1):256-258.
2017
Rutherford SC
,
Stewart EN
,
Chen Z
,
Chadburn A
,
Wehrli NE
,
van Besien K
,
Martin P
,
Furman RR
,
Leonard JP
,
Cerchietti L
. 2017.
The eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data.
.
Leuk Lymphoma. :1-3.
2013
Clozel T
,
Yang SN
,
Elstrom RL
,
Tam W
,
Martin P
,
Kormaksson M
,
Banerjee S
,
Vasanthakumar A
,
Culjkovic B
,
Scott DW
et al.
. 2013.
Mechanism-based epigenetic chemosensitization therapy of diffuse large B-cell lymphoma.
.
Cancer Discov. 3(9):1002-19.
2010
Elstrom RL
,
Martin P
,
Ostrow K
,
Barrientos J
,
Chadburn A
,
Furman R
,
Ruan J
,
Shore T
,
Schuster M
,
Cerchietti L
et al.
. 2010.
Response to second-line therapy defines the potential for cure in patients with recurrent diffuse large B-cell lymphoma: implications for the development of novel therapeutic strategies.
.
Clin Lymphoma Myeloma Leuk. 10(3):192-6.
2009
Cerchietti LC
,
Yang SNing
,
Shaknovich R
,
Hatzi K
,
Polo JM
,
Chadburn A
,
Dowdy SF
,
Melnick A
. 2009.
A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivo.
.
Blood. 113(15):3397-405.